XML 59 R45.htm IDEA: XBRL DOCUMENT v3.19.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Principles of Consolidation (Details) - USD ($)
1 Months Ended
Apr. 02, 2015
Oct. 31, 2013
Royalties and milestones | PDL BioPharma    
Debt Instrument [Line Items]    
Royalty and milestone payments received   $ 240,500,000
Senior Notes    
Debt Instrument [Line Items]    
Aggregate principal amount of notes issued $ 575,000,000.0  
Proceeds from the issuance of debt $ 562,000,000